CRYO (N° 21D588A0001) study aims to evaluate the tolerance and adjust the mode of administration of a cyto-selective difluoroethane-based cryotherapy in the treatment of brown spots. The study is a proof of concept on a small panel of subjects and has been designed to be interventional, monocentric, randomized and double blind. The study will include three device prototypes and a CE marked device (trademark URGO CRYOBEAUTY MAINS-BRAS-JAMBES) used as reference.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
TOLERABILITY : Post-treatment pain assessement
Timeframe: Day 0 (Time1 defined as 15 minutes post-treatment)
TOLERABILITY : Appearance of edemas, blisters, bubbles or scars.
Timeframe: Day 56
PERFORMANCE : Skin color evaluation
Timeframe: Day 56